Agreement will expand the availability of Gencurix’s in vitro diagnostic (IVD) assays using Droplet Digital™ PCR (ddPCR™) for clinical testing of critical oncology biomarkers across Europe
New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
Explore the benefits of a combined methylation-sensitive restriction enzyme and ddPCR approach to detect DNA methylation in healthy and disease states.
The new systems are tailored for applications such as oncology, infectious disease, genetic research, and more.
Additions to company’s range of bioanalytical antibodies and reagents enhances bioanalysis and antibody-related research
See how Bio-Rad’s Vericheck ddPCR Kit offers accuracy and ease to ensure AAV vector quality and safety for improved gene therapy outcomes
Supporting reliable assessment of AAV vector quality with precise measurement of viral titer and capsid titer
Bio-Rad leads investment to support the launch of ColoSense® to advance diagnostic innovations for inflammatory bowel disease
Newly released kits at SLAS2025 offer broad antibody compatibility and long-term stability for flow cytometry and western blot applications
Unlock small to large scale purification using weak anion exchange and hydrophobic interaction (AEX-HIC) mixed-mode chromatography resin innovation
Foresight Pro 45 cm ID column provides a convenient and reliable solution for purification of biomolecules in downstream bioprocessing
The Vericheck ddPCR Empty-Full Capsid Kit from Bio-Rad combines measuring viral titer and capsid titer, providing a high-precision assessment of both protein and DNA in droplets
Pioneering research into ddPCR technology by two leading scientists is advancing research in oncology
Annexin V StarBright™ Conjugates offer increased choice and flexibility for apoptosis detection in conventional and full spectrum flow cytometry
Bio-Rad adds rapid bispecific antibody prototyping and screening services to its Pioneer Antibody Discovery Platform
Bio-Rad outlines strategic collaborations to enable clinical evidence generation and advance precision oncology
Compact system uses CMOS digital imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 analysis software enable high-quality and affordable single-cell transcription and gene expression to support molecular biology, oncology, and drug discovery research
Antibodies validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples
Validated detection of viral replication genes using Droplet Digital™ PCR during cell and gene therapy production
Enhanced usability to support PCR applications in basic and translational research, process development, and quality control
StarBright Blue and StarBright Yellow dyes conjugated to highly validated antibodies for conventional and full spectrum flow cytometry in immunology research
Bio-Rad’s growing range of anti-idiotypic antibodies offers researchers enhanced flexibility for the development of custom bioanalytical drug assays
StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 Dyes conjugated to highly validated antibodies for multicolor panel design in immunology research
